Deficiency (Bloomington stock no.) . | Cytology . | % border cell migration defect tai61G1 (n) * . | % border cell migration defect taik05809 (n) * . | Interacting region . |
---|---|---|---|---|
Df(1)v-N48 (3560) | 9F; 10C3-5 | 19 (333) | 13 (192) | 9F-10A9 |
Df(1)KA7 (957) † | 10A9;10F6-7 | 0 (≥100) | 0 (≥75) | |
Df(1)N19 (970) | 17A1;18A2 | 8 (184) | 10 (77) | 17A1-18A2 |
Df(2L)Dwee-delta5 (3571) | 27A;28A | 15 (209) | 10 (88) | 27A-C1 |
Df(2L)BSC7 (6374) | 26D10-E1;27C1 | 10 (98) | 15 (162) | |
Df(2L)J-H (1357) | 27C2-9;28B3-4 | 0 (≥100) | 1 (123) | |
Df(2L)J39 (1469) | 31C-D;32D1-E5 | 47 (131) | Lethal ‡ | 31C-32A2 |
Df(2L)J2 (3366) | 31B1;32A1-2 | 34 (85) | 18 (62) | |
Df(2R)M60E (2471) | 60E2-3;60E11-12 | 9 (200) | Semi-lethal § | 60E2-12 |
Df(3L)GN24 (3686) | 63F6-7;64C13-15 | 22 (271) | 37 (82) | 63F6-64B12 |
Df(3L)10H | 64B10-12;64C5-7 | 0 (≥100) | 1 (≥82) | |
Df(3L)AC1 (997) | 67A2;67D7-13 | 26 (231) | 14 (66) | 67B1-D13 |
Df(3L)29A6 (2479) | 66F5;67B1 | 0 (≥100) | 0 (≥75) | |
Df(3L)fz-GF3b (3124) ¶ | 70C1-2;70D4-5 | 10 (281) | 6 (200) | 70C1-D5 |
Df(3R)3-4 (4787) | 82F3-4;82F10-11 | 12 (180) | 4 (265) | 82F3-11 |
Df(3R)by10 (1931) | 85D8-12;85E7-F1 | 14 (206) | 15 (125) | 85D11-F1 |
Df(3R)by62 (1893) | 85D11-14;85F6 | 20 (153) | 7 (97) | |
Tp(3;Y)ry506-85C (1534) | 87D1-2;88E5-6 | 8 (164) | Semi-lethal § | 87D1-88E6 |
Df(3R)H-B79 (4962) ** | 92B3;92F13 | 20 (185) | 12 (169) | 92B3-F13 |
Df(3R)crb-F89-4 (4432) | 95D7-D11;95F15 | 12 (272) | 12 (146) | 95E8-F7 |
Df(3R)crb87-4 (2362) | 95E8-F1;95F15 | 13 (304) | 22 (189) | |
Df(3R)crb87-5 (2363) | 95F7;96A17-18 | 0 (100) | 4 (124) | |
Df(3R)3450 (430) | 98E3;99A6-8 | 11 (278) | 10 (114) | 98E3-99A8 |
Deficiency (Bloomington stock no.) . | Cytology . | % border cell migration defect tai61G1 (n) * . | % border cell migration defect taik05809 (n) * . | Interacting region . |
---|---|---|---|---|
Df(1)v-N48 (3560) | 9F; 10C3-5 | 19 (333) | 13 (192) | 9F-10A9 |
Df(1)KA7 (957) † | 10A9;10F6-7 | 0 (≥100) | 0 (≥75) | |
Df(1)N19 (970) | 17A1;18A2 | 8 (184) | 10 (77) | 17A1-18A2 |
Df(2L)Dwee-delta5 (3571) | 27A;28A | 15 (209) | 10 (88) | 27A-C1 |
Df(2L)BSC7 (6374) | 26D10-E1;27C1 | 10 (98) | 15 (162) | |
Df(2L)J-H (1357) | 27C2-9;28B3-4 | 0 (≥100) | 1 (123) | |
Df(2L)J39 (1469) | 31C-D;32D1-E5 | 47 (131) | Lethal ‡ | 31C-32A2 |
Df(2L)J2 (3366) | 31B1;32A1-2 | 34 (85) | 18 (62) | |
Df(2R)M60E (2471) | 60E2-3;60E11-12 | 9 (200) | Semi-lethal § | 60E2-12 |
Df(3L)GN24 (3686) | 63F6-7;64C13-15 | 22 (271) | 37 (82) | 63F6-64B12 |
Df(3L)10H | 64B10-12;64C5-7 | 0 (≥100) | 1 (≥82) | |
Df(3L)AC1 (997) | 67A2;67D7-13 | 26 (231) | 14 (66) | 67B1-D13 |
Df(3L)29A6 (2479) | 66F5;67B1 | 0 (≥100) | 0 (≥75) | |
Df(3L)fz-GF3b (3124) ¶ | 70C1-2;70D4-5 | 10 (281) | 6 (200) | 70C1-D5 |
Df(3R)3-4 (4787) | 82F3-4;82F10-11 | 12 (180) | 4 (265) | 82F3-11 |
Df(3R)by10 (1931) | 85D8-12;85E7-F1 | 14 (206) | 15 (125) | 85D11-F1 |
Df(3R)by62 (1893) | 85D11-14;85F6 | 20 (153) | 7 (97) | |
Tp(3;Y)ry506-85C (1534) | 87D1-2;88E5-6 | 8 (164) | Semi-lethal § | 87D1-88E6 |
Df(3R)H-B79 (4962) ** | 92B3;92F13 | 20 (185) | 12 (169) | 92B3-F13 |
Df(3R)crb-F89-4 (4432) | 95D7-D11;95F15 | 12 (272) | 12 (146) | 95E8-F7 |
Df(3R)crb87-4 (2362) | 95E8-F1;95F15 | 13 (304) | 22 (189) | |
Df(3R)crb87-5 (2363) | 95F7;96A17-18 | 0 (100) | 4 (124) | |
Df(3R)3450 (430) | 98E3;99A6-8 | 11 (278) | 10 (114) | 98E3-99A8 |
Number of egg chambers examined.
Overlapping deficiencies are indented; deficiencies from the deficiency kit are not indented.
Lethal in taik05809/Df(2L)J39 females.
Semi-lethal in taik05809/+;Df/+ females; border cell migration could not be determined.
Df(3L)fz-GF3b exhibits a variable phenotype and is semi-haploinsufficient;6% of Df(3L)fz-GF3b/TM6 egg chambers have border cell migration defects(n=159).
Df(3R)H-B79 removes Stat92E, which is haploinsufficient for border cell migration (Silver and Montell,2001); Df(3R)H-B79/TM2 females exhibit ∼10% border cell migration defect (n=101).